ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 22 Wed April Expiry

Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 22 Wed April Expiry Which Call CE or PUT PE options to buy or sell in Arrowhead Pharmaceuticals, Inc. ARWR

0   ARWR Most Active Call Put Options

ARWR SPOT Price: 71.05 as on 21 Apr, 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) target & price

ARWR Target Price
Target up: 74.72
Target up: 72.88
Target up: 72.19
Target up: 71.49
Target down: 69.65
Target down: 68.96
Target down: 68.26

Date Close Open High Low Volume
21 Tue Apr 202671.0571.9373.3270.092.21 M
20 Mon Apr 202669.2569.2170.4868.091.2 M
17 Fri Apr 202669.5169.7770.8968.824.33 M
16 Thu Apr 202667.9871.4772.1867.421.95 M
15 Wed Apr 202670.9566.6970.9766.612.2 M
14 Tue Apr 202666.6963.9867.4963.981.47 M
13 Mon Apr 202663.7965.1067.2963.271.77 M
10 Fri Apr 202665.1466.5266.5264.811.67 M
Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 22 Wed April Expiry

ARWR Option Chain Data Analysis for Arrowhead Pharmaceuticals, Inc. ARWR option chain

Maximum Call writing has been for strikes:
Until yesterday Maximum Call writing has been for strikes:

Open Interest of Call writers for the options of Arrowhead Pharmaceuticals, Inc. ARWR is shifting downwards. This would mean that markets are slowly moving downwards, and buying CALLS and CE might not be profitable.

Maximum Put writing has been for strikes:
Until yesterday Maximum Put writing has been for strikes:

Open Interest of PUT writers for the options of Arrowhead Pharmaceuticals, Inc. ARWR is shifting downwards. This would mean that markets are slowly moving downwards, and buying PUTS and PE might be more profitable. However, above mentioned levels will serve as support so avoid buying PE below those above mentioned levels.

ARWR Option Chain Price Analysis for Arrowhead Pharmaceuticals, Inc. ARWR option chain

Stock is in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Arrowhead Pharmaceuticals, Inc. ARWR at this time.

It appears as if Arrowhead Pharmaceuticals, Inc. ARWR gave a large move recently.

Stock of Arrowhead Pharmaceuticals, Inc. (ARWR) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might move higher!

My analysis of Arrowhead Pharmaceuticals, Inc. is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Arrowhead Pharmaceuticals, Inc. stays above 68.2, but if it comes below 68.2, then a intra day sell could be more profitable.
If you take a sell trade below 68.2, then use 68.2 as stoploss and 63.86 as target. However if you take a buy trade in Arrowhead Pharmaceuticals, Inc., then use 68.2 as stoploss and 73.4 as target.

Arrowhead Pharmaceuticals, Inc. ARWR Option Chain, OTM CE, ITM PE

Below is full option chain of Arrowhead Pharmaceuticals, Inc. for strikes which are OTM CALLS (CE), and ITM PUTS (PE).
These are CALLS which have only time value in them, no intrinsic value. PUTS however have both time value and intrinsic value in the premium.

Arrowhead Pharmaceuticals, Inc. ARWR Option Chain, ITM CE, OTM PE

Below is full option chain of Arrowhead Pharmaceuticals, Inc. for strikes which are ITM CALLS (CE), and OTM PUTS (PE).
These are PUTS which have only time value in them, no intrinsic value. CALLS however have both time value and intrinsic value in the premium.

Videos related to: Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 22 Wed April Expiry

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Basics How To Trade In FnO Futures Options Stock Market

Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 22 Wed April Expiry

 

Back to top